Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Effect of Diabecon on sugar-induced lens opacity in organ culture: mechanism of action.

Moghaddam MS, Kumar PA, Reddy GB, Ghole VS.

J Ethnopharmacol. 2005 Feb 28;97(2):397-403. Epub 2005 Jan 18.

PMID:
15707781
2.

[Aldose reductase inhibitors].

Dostert P, Strolin Benedetti M.

J Pharmacol. 1986 Oct-Dec;17(4):483-96. Review. French.

PMID:
3104688
3.

Contribution of polyol pathway to diabetes-induced oxidative stress.

Chung SS, Ho EC, Lam KS, Chung SK.

J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S233-6. Review.

4.

Sugar metabolism in the crystalline lens.

Chylack LT Jr, Cheng HM.

Surv Ophthalmol. 1978 Jul-Aug;23(1):26-37. Review.

PMID:
100892
5.

[The role of polyol pathways in formation of diabetic cataracts].

SabasiƄski K, Andrzejewska-Buczko J.

Klin Oczna. 1997;99(6):401-4. Review. Polish.

PMID:
9685789
6.

Medical therapy in the prevention of cataract.

Brown NA, Bron AJ.

Trans Ophthalmol Soc U K. 1985;104 ( Pt 7):748-54. Review.

PMID:
3938085
7.

The lens in diabetes.

Bron AJ, Sparrow J, Brown NA, Harding JJ, Blakytny R.

Eye (Lond). 1993;7 ( Pt 2):260-75. Review.

PMID:
7607346
8.

Drugs designed to maintain the transparence of the ocular lens.

Chanalet L, Lapalus P.

Fundam Clin Pharmacol. 1994;8(4):322-41. Review.

PMID:
7851838
9.

Lens aldose reductase in diabetic and galactosemic cataracts.

Parmar NS, Ghosh MN.

Indian J Physiol Pharmacol. 1981 Jul-Sep;25(3):193-200. Review. No abstract available.

PMID:
6795119
10.

A thirty year journey in the polyol pathway.

Kinoshita JH.

Exp Eye Res. 1990 Jun;50(6):567-73. Review.

PMID:
2115448
11.

Pharmacological prevention of diabetic cataract.

Kyselova Z, Stefek M, Bauer V.

J Diabetes Complications. 2004 Mar-Apr;18(2):129-40. Review.

PMID:
15120709
12.

[Cataract prevention. Therapeutic approaches and critical review of current status].

Wegener A.

Ophthalmologe. 2003 Mar;100(3):176-80. Review. German.

PMID:
12640545
13.

Gymnema sylvestre for diabetes mellitus: a systematic review.

Leach MJ.

J Altern Complement Med. 2007 Nov;13(9):977-83. Review.

PMID:
18047444
14.

Can cataract be prevented?

Harding JJ.

Eye (Lond). 1999 Jun;13 ( Pt 3b):454-6. Review.

PMID:
10627824
15.

An overview on the advances of Gymnema sylvestre: chemistry, pharmacology and patents.

Porchezhian E, Dobriyal RM.

Pharmazie. 2003 Jan;58(1):5-12. Review.

PMID:
12622244
16.

Advances in pharmacological strategies for the prevention of cataract development.

Gupta SK, Selvan VK, Agrawal SS, Saxena R.

Indian J Ophthalmol. 2009 May-Jun;57(3):175-83. doi: 10.4103/0301-4738.49390. Review.

17.

Cytoprotective mechanism of action of curcumin against cataract.

Raman T, Ramar M, Arumugam M, Nabavi SM, Varsha MK.

Pharmacol Rep. 2016 Jun;68(3):561-9. doi: 10.1016/j.pharep.2015.12.012. Epub 2016 Jan 22. Review.

PMID:
26894964

Supplemental Content

Support Center